← FDA Drug Approvals (Drugs@FDA)
GRISEOFULVIN, ULTRAMICROSIZE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2018-12-26
Drug application
- FDA Application #
ANDA202805- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GRISEOFULVIN, ULTRAMICROSIZE
- Generic name
- ULTRAMICROSIZE GRISEOFULVIN
- Active ingredients
- GRISEOFULVIN, ULTRAMICROSIZE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SANDOZ
- Manufacturer
- Sandoz Inc
- First approval
- 2018-12-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown